Labco

September 7, 2010, 7:27 am

≫ Next: Labco

$

0

0

Nature de l'opération: 

Participation

Date d'entrée: 

2009

Labco is the leading pan European medical diagnostics network.
The network includes more than 300 laboratories operated by close to 4,000 healthcare professionals in six countries. Crédit Agricole Private Equity, through its Co-Investment and small cap LBO & Expansion funds, contributed EUR 15 million to the share capital increase led by 3i in July 2008, participating in the exceptional growth of the Labco network.

www.labco.eu

---

Labco

September 9, 2010, 4:09 am

≫ Next: EA Pharma

≪ Previous: Labco

$

0

0

Nature de l'opération: 

Participation

Date d'entrée: 

2009

Labco is the leading pan European medical diagnostics network.
The network includes more than 300 laboratories operated by close to 4,000 healthcare professionals in six countries. Crédit Agricole Private Equity, through its Co-Investment and small cap LBO & Expansion funds, contributed EUR 15 million to the share capital increase led by 3i in July 2008, participating in the exceptional growth of the Labco network.

www.labco.eu

EA Pharma

September 9, 2010, 4:11 am

≫ Next: Dynaction

≪ Previous: Labco

$

0

0

Nature de l'opération: 

Participation

Date d'entrée: 

2009

Formed from the merger in 2006 between Laboratoire des Granions (Monaco) and Equilibre Attitude (Alpes Maritimes), the Group designs and sells a range of medicines and food supplements in the area of nutritherapy. EA Pharma targets three main segments: oligo-elements, food supplements and sports nutrition.

www.ea-pharma.com

Dynaction

September 9, 2010, 5:05 am

≫ Next: Vivalto Santé

≪ Previous: EA Pharma

$

0

0

Nature de l'opération: 

Participation

Date d'entrée: 

2000

Dynaction is an industrial holding company that has focused on just one area of development since late December 2005: Speciality Fine Chemicals, the business area of subsidiary PCAS, in which it holds a majority stake of 68%.

www.dynaction.fr

Vivalto Santé

September 10, 2010, 1:25 am

≫ Next: Amakem

≪ Previous: Dynaction

$

0

0

Nature de l'opération: 

Participation

Date d'entrée: 

2009

Market leader in private clinics in Brittany (France), Vivalto Santé owns three care homes in the region ranked among the best in France, in Rennes, Saint-Malo and Brest. Vivalto Santé has short-term private hospital stay facilities of 725 beds. The Group has 1,300 employees and 240 medical practitioners.

See press release

Amakem

September 14, 2011, 7:58 am

≫ Next: Ameos

≪ Previous: Vivalto Santé

$

0

0

Nature de l'opération: 

Participation

Date d'entrée: 

2011

Founded in 2010, Amakem is an ophthalmology company developing new treatments for serious eye conditions. Amakem’s product pipeline is based on its unique Localized Drug Action platform which is designed to generate safe and effective novel kinase inhibitors that minimize systemic exposure with the aim of reducing side effects.

www.amakem.com

http://www.ca-privateequity.com/en/news/press-releases/credit-agricole-private-e...

read more

Ameos

April 11, 2012, 12:50 am

≫ Next: Enterome

≪ Previous: Amakem

$

0

0

Nature de l'opération: 

Participation

Date d'entrée: 

2012

Headquartered in Zurich, Ameos was founded in 2002 by Dr Axel Paeger and German private equity firm Quadriga Capital. The group is the fifth private hospitals operator in Germany. It operates 46 hospitals (general and psychiatric) in Germany and 2 hospitals in Austria.

In April 2012, Crédit Agricole Private Equity (that becomes Omnes Capital) participated in a capital increase, alongside Quadriga Capital and the Carlyle Group, to fund the steady growth of the Ameos Group.

Enterome

June 12, 2012, 5:55 am

≫ Next: Pixium

≪ Previous: Ameos

$

0

0

Nature de l'opération: 

Participation

Date d'entrée: 

2012

Based in Paris, Enterome is a medicine company dedicated to the identification and development of drugs and biomarkers based on altered gut microbiota, for chronic and challenging medical conditions relating to abnormalities of bacterial composition of the human intestine.

www.enterome.com

---

Pixium

June 12, 2012, 6:14 am

≫ Next: Labco

≪ Previous: Enterome

$

0

0

Nature de l'opération: 

Participation

Date d'entrée: 

2012

Created in 2011 and based in Paris, Pixium is specialized in the development of next generation retinal implants to treat blindness caused by retinal dystrophy and other degenerations. Pixium combines an existing technology from the company Intelligent Medical Implant and the latest innovative technologies for sensors, data processing, electrodes...

Labco

September 7, 2010, 7:27 am

≫ Next: Labco

≪ Previous: Pixium

$

0

0

Nature de l'opération: 

Participation

Date d'entrée: 

2009

Labco is the leading pan European medical diagnostics network.
The network includes more than 300 laboratories operated by close to 4,000 healthcare professionals in six countries. Omnes Capital, through its Co-Investment and small cap LBO & Expansion funds, contributed EUR 15 million to the share capital increase led by 3i in July 2008, participating in the exceptional growth of the Labco network.

www.labco.eu

Labco

September 9, 2010, 4:09 am

≫ Next: EA Pharma

≪ Previous: Labco

$

0

0

Nature de l'opération: 

Participation

Date d'entrée: 

2009

Labco is the leading pan European medical diagnostics network.
The network includes more than 300 laboratories operated by close to 4,000 healthcare professionals in six countries. Omnes Capital, through its Co-Investment and small cap LBO & Expansion funds, contributed EUR 15 million to the share capital increase led by 3i in July 2008, participating in the exceptional growth of the Labco network.

www.labco.eu

EA Pharma

September 9, 2010, 4:11 am

≫ Next: Dynaction

≪ Previous: Labco

$

0

0

Nature de l'opération: 

Participation

Date d'entrée: 

2009

Formed from the merger in 2006 between Laboratoire des Granions (Monaco) and Equilibre Attitude (Alpes Maritimes), the Group designs and sells a range of medicines and food supplements in the area of nutritherapy. EA Pharma targets three main segments: oligo-elements, food supplements and sports nutrition.

www.ea-pharma.com

Dynaction

September 9, 2010, 5:05 am

≫ Next: Vivalto Santé

≪ Previous: EA Pharma

$

0

0

Nature de l'opération: 

Participation

Date d'entrée: 

2000

Dynaction is an industrial holding company that has focused on just one area of development since late December 2005: Speciality Fine Chemicals, the business area of subsidiary PCAS, in which it holds a majority stake of 68%.

www.dynaction.fr

Vivalto Santé

September 10, 2010, 1:25 am

≫ Next: Amakem

≪ Previous: Dynaction

$

0

0

Nature de l'opération: 

Participation

Date d'entrée: 

2009

Market leader in private clinics in Brittany (France), Vivalto Santé owns three care homes in the region ranked among the best in France, in Rennes, Saint-Malo and Brest. Vivalto Santé has short-term private hospital stay facilities of 725 beds. The Group has 1,300 employees and 240 medical practitioners.

See press release

Amakem

September 14, 2011, 7:58 am

≫ Next: Ameos

≪ Previous: Vivalto Santé

$

0

0

Nature de l'opération: 

Participation

Date d'entrée: 

2011

Founded in 2010, Amakem is an ophthalmology company developing new treatments for serious eye conditions. Amakem’s product pipeline is based on its unique Localized Drug Action platform which is designed to generate safe and effective novel kinase inhibitors that minimize systemic exposure with the aim of reducing side effects.

www.amakem.com

http://omnescapital.com/en/news/press-releases/credit-agricole-private-equity-pa...

read more

---

Ameos

April 11, 2012, 12:50 am

≫ Next: Enterome

≪ Previous: Amakem

$

0

0

Nature de l'opération: 

Participation

Date d'entrée: 

2012

Headquartered in Zurich, Ameos was founded in 2002 by Dr Axel Paeger and German private equity firm Quadriga Capital. The group is the fifth private hospitals operator in Germany. It operates 46 hospitals (general and psychiatric) in Germany and 2 hospitals in Austria.

In April 2012, Omnes Capital participated in a capital increase, alongside Quadriga Capital and the Carlyle Group, to fund the steady growth of the Ameos Group.

Enterome

June 12, 2012, 6:23 am

≫ Next: Pixium

≪ Previous: Ameos

$

0

0

Nature de l'opération: 

Participation

Date d'entrée: 

2012

Based in Paris, Enterome is a medicine company dedicated to the identification and development of drugs and biomarkers based on altered gut microbiota, for chronic and challenging medical conditions relating to abnormalities of bacterial composition of the human intestine.

www.enterome.com

Pixium

June 12, 2012, 6:24 am

≪ Previous: Enterome

$

0

0

Nature de l'opération: 

Participation

Date d'entrée: 

2012

Created in 2011 and based in Paris, Pixium is specialized in the development of next generation retinal implants to treat blindness caused by retinal dystrophy and other degenerations. Pixium combines an existing technology from the company Intelligent Medical Implant and the latest innovative technologies for sensors, data processing, electrodes...